Literature DB >> 16365290

A 200-kb region of human chromosome 22q11.2 confers antipsychotic-responsive behavioral abnormalities in mice.

Noboru Hiroi1, Hongwen Zhu, Moonsook Lee, Birgit Funke, Makoto Arai, Masanari Itokawa, Raju Kucherlapati, Bernice Morrow, Takehito Sawamura, Soh Agatsuma.   

Abstract

Human chromosome 22q11.2 has been implicated in various behavioral abnormalities, including schizophrenia and other neuropsychiatric/behavioral disorders. However, the specific genes within 22q11.2 that contribute to these disorders are still poorly understood. Here, we show that an approximately 200-kb segment of human 22q11.2 causes specific behavioral abnormalities in mice. Mice that overexpress an approximately 200-kb region of human 22q11.2, containing CDCrel, GP1Bbeta, TBX1, and WDR14, exhibited spontaneous sensitization of hyperactivity and a lack of habituation. These effects were ameliorated by antipsychotic drugs. The transgenic mice were also impaired in nesting behavior. Although Tbx1 has been shown to be responsible for many physical defects associated with 22q11.2 haploinsufficiency, Tbx1 heterozygous mice did not display these behavioral abnormalities. Our results show that the approximately 200-kb region of 22q11.2 contains a gene(s) responsible for behavioral abnormalities and suggest that distinct genetic components within 22q11.2 mediate physical and behavioral abnormalities.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16365290      PMCID: PMC1323212          DOI: 10.1073/pnas.0509635102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  58 in total

1.  Evaluation of dopamine D-2 receptor occupancy by clozapine, risperidone, and haloperidol in vivo in the rodent and nonhuman primate brain using 18F-fallypride.

Authors:  J Mukherjee; B T Christian; T K Narayanan; B Shi; J Mantil
Journal:  Neuropsychopharmacology       Date:  2001-10       Impact factor: 7.853

2.  Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor epsilon1 subunit.

Authors:  Y Miyamoto; K Yamada; Y Noda; H Mori; M Mishina; T Nabeshima
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

3.  Lower prepulse inhibition in children with the 22q11 deletion syndrome.

Authors:  Christina Sobin; Karen Kiley-Brabeck; Maria Karayiorgou
Journal:  Am J Psychiatry       Date:  2005-06       Impact factor: 18.112

4.  DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1.

Authors:  L A Jerome; V E Papaioannou
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

5.  TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome.

Authors:  S Merscher; B Funke; J A Epstein; J Heyer; A Puech; M M Lu; R J Xavier; M B Demay; R G Russell; S Factor; K Tokooya; B S Jore; M Lopez; R K Pandita; M Lia; D Carrion; H Xu; H Schorle; J B Kobler; P Scambler; A Wynshaw-Boris; A I Skoultchi; B E Morrow; R Kucherlapati
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

6.  Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice.

Authors:  E A Lindsay; F Vitelli; H Su; M Morishima; T Huynh; T Pramparo; V Jurecic; G Ogunrinu; H F Sutherland; P J Scambler; A Bradley; A Baldini
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

Review 7.  22q11.2 duplication syndrome: two new familial cases with some overlapping features with DiGeorge/velocardiofacial syndromes.

Authors:  Marie-France Portnoï; Fanny Lebas; Nicolas Gruchy; Azarnouche Ardalan; Valérie Biran-Mucignat; Valérie Malan; Lina Finkel; Gilles Roger; Sarah Ducrocq; Francis Gold; Jean-Louis Taillemite; Sandrine Marlin
Journal:  Am J Med Genet A       Date:  2005-08-15       Impact factor: 2.802

8.  Mice deleted for the DiGeorge/velocardiofacial syndrome region show abnormal sensorimotor gating and learning and memory impairments.

Authors:  R Paylor; K L McIlwain; R McAninch; A Nellis; L A Yuva-Paylor; A Baldini; E A Lindsay
Journal:  Hum Mol Genet       Date:  2001-11-01       Impact factor: 6.150

Review 9.  Behavioural pharmacology of the new generation of antipsychotic agents.

Authors:  N A Moore
Journal:  Br J Psychiatry Suppl       Date:  1999

10.  Mice overexpressing genes from the 22q11 region deleted in velo-cardio-facial syndrome/DiGeorge syndrome have middle and inner ear defects.

Authors:  B Funke; J A Epstein; L K Kochilas; M M Lu; R K Pandita; J Liao; R Bauerndistel; T Schüler; H Schorle; M C Brown; J Adams; B E Morrow
Journal:  Hum Mol Genet       Date:  2001-10-15       Impact factor: 6.150

View more
  26 in total

Review 1.  Genome-wide approaches to schizophrenia.

Authors:  Jubao Duan; Alan R Sanders; Pablo V Gejman
Journal:  Brain Res Bull       Date:  2010-04-28       Impact factor: 4.077

Review 2.  Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap.

Authors:  Judith Pratt; Catherine Winchester; Neil Dawson; Brian Morris
Journal:  Nat Rev Drug Discov       Date:  2012-06-22       Impact factor: 84.694

3.  Dosage sensitivity intolerance of VIPR2 microduplication is disease causative to manifest schizophrenia-like phenotypes in a novel BAC transgenic mouse model.

Authors:  Xinli Tian; Adam Richard; Madison Wynne El-Saadi; Aakriti Bhandari; Brian Latimer; Isabella Van Savage; Kevlyn Holmes; Ronald L Klein; Donard Dwyer; Nicholas E Goeders; X William Yang; Xiao-Hong Lu
Journal:  Mol Psychiatry       Date:  2019-08-23       Impact factor: 15.992

Review 4.  Critical reappraisal of mechanistic links of copy number variants to dimensional constructs of neuropsychiatric disorders in mouse models.

Authors:  Noboru Hiroi
Journal:  Psychiatry Clin Neurosci       Date:  2018-03-01       Impact factor: 5.188

Review 5.  Molecular mechanisms in 22q11 deletion syndrome.

Authors:  Nigel M Williams
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

Review 6.  Analyses of the associations between the genes of 22q11 deletion syndrome and schizophrenia.

Authors:  Tadao Arinami
Journal:  J Hum Genet       Date:  2006-09-13       Impact factor: 3.172

7.  Tbx1: identification of a 22q11.2 gene as a risk factor for autism spectrum disorder in a mouse model.

Authors:  Takeshi Hiramoto; Gina Kang; Go Suzuki; Yasushi Satoh; Raju Kucherlapati; Yasuhiro Watanabe; Noboru Hiroi
Journal:  Hum Mol Genet       Date:  2011-09-09       Impact factor: 6.150

8.  Over-expression of a human chromosome 22q11.2 segment including TXNRD2, COMT and ARVCF developmentally affects incentive learning and working memory in mice.

Authors:  Go Suzuki; Kathryn M Harper; Takeshi Hiramoto; Birgit Funke; MoonSook Lee; Gina Kang; Mahalah Buell; Mark A Geyer; Raju Kucherlapati; Bernice Morrow; Pekka T Männistö; Soh Agatsuma; Noboru Hiroi
Journal:  Hum Mol Genet       Date:  2009-07-19       Impact factor: 6.150

Review 9.  Copy number variation at 22q11.2: from rare variants to common mechanisms of developmental neuropsychiatric disorders.

Authors:  N Hiroi; T Takahashi; A Hishimoto; T Izumi; S Boku; T Hiramoto
Journal:  Mol Psychiatry       Date:  2013-08-06       Impact factor: 15.992

Review 10.  Failure of neuronal homeostasis results in common neuropsychiatric phenotypes.

Authors:  Melissa B Ramocki; Huda Y Zoghbi
Journal:  Nature       Date:  2008-10-16       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.